Dopaminerge lægemidler til behandling af depression

Daniel Burmester, Carl Michael von Buchwald, Poul Videbech

Abstract

A significant proportion of patients with depression do not respond to classic antidepressants addressing serotonergic or noradrenergic neurotransmission. Certain clinical features of depression seem to involve dopaminergic neurotransmission. Although medications with specific dopaminergic actions are used in the treatment of depression in other countries (e.g. the United States), these drugs are rarely mentioned in Danish treatment guidelines. This review aims at comprehending current dopaminergic treatment strategies and future directions in this field.

Bidragets oversatte titelDopaminergic drugs in the treatment of depression
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind183
Udgave nummer47
ISSN0041-5782
StatusUdgivet - 22 nov. 2021

Emneord

  • Antidepressive Agents/therapeutic use
  • Depression/drug therapy
  • Dopamine
  • Dopamine Agents
  • Humans
  • Norepinephrine

Fingeraftryk

Dyk ned i forskningsemnerne om 'Dopaminerge lægemidler til behandling af depression'. Sammen danner de et unikt fingeraftryk.

Citationsformater